CFTR and cystic fibrosis: To investigate the effects of acute versus chronic ivacaftor treatment in highly differentiated primary airway epithelial cells, we grew nasal epithelial cultures from patients with CF homozygous for F508del-CFTR and first studied them under conditions that were previously used in experiments demonstrating that ivacaftor reduces pharmacological rescue in combination with the corrector compound lumacaftor (26).